Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
MED12L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
P2RY14 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GPR87 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GPR171 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
P2RY13 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
P2RY12 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CLRN1-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
IGSF10 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CLRN1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AADACL2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SIAH2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AADACP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ERICH6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SELT - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on